Prostate Cancer Trial, Recruiting (NCT06773598)

Prostate Cancer Trial, Recruiting NCT06773598 Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06773598 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older at the time of the examination
People who have given their written agreement (informed consent) to take part
People who have one or more areas of concern found on a prostate MRI scan, rated on a standard scoring system (PI-RADSv2.1) with a score of 1 or higher, at the IRCCS Azienda Ospedaliero-Universitaria hospital in Bologna
People for whom doctors at the IRCCS Azienda Ospedaliero-Universitaria hospital in Bologna have recommended a specific type of prostate biopsy that combines ultrasound-guided targeting with a broader sampling approach

Who may not be able to join:

People who have previously had prostate surgery or received hormone therapy for prostate conditions
People whose scan results are too poor in quality to be used, for example due to interference caused by a hip replacement, movement during the scan, or similar issues

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Caterina Gaudiano, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phone: +39 0515142307

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06773598

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: +39 0515142307

More information: https://clinicaltrials.gov/study/NCT06773598

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older at the time of the examination
People who have given their written agreement (informed consent) to take part
People who have one or more areas of concern found on a prostate MRI scan, rated on a standard scoring system (PI-RADSv2.1) with a score of 1 or higher, at the IRCCS Azienda Ospedaliero-Universitaria hospital in Bologna
People for whom doctors at the IRCCS Azienda Ospedaliero-Universitaria hospital in Bologna have recommended a specific type of prostate biopsy that combines ultrasound-guided targeting with a broader sampling approach

Who may not be able to join:

People who have previously had prostate surgery or received hormone therapy for prostate conditions
People whose scan results are too poor in quality to be used, for example due to interference caused by a hip replacement, movement during the scan, or similar issues

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Registry

ClinicalTrials.gov

Start date

21 May 2024

Est. completion

1 October 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Specificity (SP); Sensitivity (SN); Positive Predictive Value (PPV); Negative Predictive Value (NPV)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov